Wordt geladen...
Immunotherapeutic and Targeted Approaches in Multiple Myeloma
The multiple myeloma (MM) therapeutic landscape has evolved significantly with the approval of numerous novel agents, including next generation proteasome inhibitors (PIs), immunomodulatory agents (IMIDs), and monoclonal antibodies (MoABs) targeting CD38 and SLAMF7. While these discoveries have led...
Bewaard in:
| Gepubliceerd in: | Immunotargets Ther |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569026/ https://ncbi.nlm.nih.gov/pubmed/33117743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S240886 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|